(S)-4-Iodo-1-(pyrrolidin-3-yl)-1H-pyrazole hydrochloride, 1g

1-(Furan-2-carbonyl)piperidine-2-carboxylic acid, 95+%, 250mg

1-(2-(Difluoromethoxy)-4-fluorophenyl)ethan-1-ol, 1g

HPLC Guard Columns (analytical) NUCLEODUR® C18 Pyramid, 3 Piece(s)

tert-Butyl 4-oxoimidazolidine-1-carboxylate, 98%, 250mg

(S)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione (Linagliptin Impurity), 97%, 50mg

2-(1h-Imidazol-1-yl)acetimidamide, 97%, 250mg

3-Fluoro-4-pyridinecarboxylic acid, 98.0%, 500g

2-(Chloromethyl)-4-(trifluoromethyl)pyridine, 95.0%, 250mg

2-amino-3,5-dibromopyridin-4-ol, 95.0%, 1g

tert-Butyl 3,6,9,12,15,18,21-heptaoxatetracos-23-yn-1-ylcarbamate, 95%, 1g

Ethylene Glycol Bis(4-carboxyphenyl) Ether>95.0%(T)5g

Methyl 2-(4-aminophenyl)propanoate, 95.0%, 1g